Seminar Archive Detail

Potent and Selective Inhibitors of the Insulin-Like Growth Factor Receptor (IGF-1R): Novel Agents for the Treatment of Cancer

Organic Seminar
Brad Shotwell
Ph.D..
GlaxoSmithKline
9/17/10